NCT02817685

Brief Summary

This study is a randomized control prospective study. The aim of this study is to establish an all-round and convenient follow-up strategy of Chronic Hepatitis B for early detection and diagnosis of Hepatocellular Carcinoma (HCC), by investigating whether different surveillance time intervals and surveillance methods are beneficial for chronic hepatitis B and cirrhotic patients with different risk of HCC.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7,660

participants targeted

Target at P75+ for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2016

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 27, 2016

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 29, 2016

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2020

Completed
Last Updated

June 29, 2016

Status Verified

June 1, 2016

Enrollment Period

4 years

First QC Date

June 27, 2016

Last Update Submit

June 27, 2016

Conditions

Keywords

surveillancehepatocellular carcinomaultrasoundcirrhosischronic hepatitis B

Outcome Measures

Primary Outcomes (1)

  • The incidence of Hepatocellular carcinoma

    3 year

Study Arms (6)

1

Chronic Hepatitis B patient

Other: 3 months

2

Chronic Hepatitis B patient

Other: 6 months

3

cirrhotic patient

Other: 3 months

4

cirrhotic patient

Other: 6 months

5

ultrasound-difficult patient

Other: 3 month ultrasound(US)+3 month CT/MRI+3 month US+3 month CT/MRI

6

ultrasound-difficult patient

Other: 6 months

Interventions

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Chronic Hepatitis B patients

You may qualify if:

  • HBV-Ag positive( \>6 months)
  • age among 18 and 80 years

You may not qualify if:

  • patients with hepatocellular carcinoma
  • patients with alcoholic hepatitis or autoimmune hepatitis
  • patients with severe uncontrolled disease resulting in estimated life expectance less than 1 year
  • coinfection with human immunodeficiency virus(HIV)
  • cannot undergo contrast-enhanced imaging
  • refuse attending the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The department of Ultrasound, the third affiliated hospital of Sun Yat-sen University

Guangzhou, Guangdong, China

RECRUITING

MeSH Terms

Conditions

Hepatitis B, ChronicCarcinoma, HepatocellularFibrosis

Condition Hierarchy (Ancestors)

Hepatitis BBlood-Borne InfectionsCommunicable DiseasesInfectionsHepadnaviridae InfectionsDNA Virus InfectionsVirus DiseasesHepatitis, Viral, HumanHepatitis, ChronicHepatitisLiver DiseasesDigestive System DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsAdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsLiver NeoplasmsDigestive System NeoplasmsNeoplasms by Site

Study Officials

  • zhongzhen zz Su, doctor

    The department of Ultrasound, the third affiliated hospital of Sun Yat-sen University

    STUDY DIRECTOR

Central Study Contacts

zhongzhen zz Su, doctor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 27, 2016

First Posted

June 29, 2016

Study Start

May 1, 2016

Primary Completion

May 1, 2020

Last Updated

June 29, 2016

Record last verified: 2016-06

Data Sharing

IPD Sharing
Will not share

Locations